Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease

This publication has 51 references indexed in Scilit:

• HIV‐1 Tat‐Mediated Activation of Glycogen Synthase Kinase‐3β Contributes to Tat‐Mediated Neurotoxicity
  Journal of Neurochemistry, 1999
• Phosphorylation of tau protein by recombinant GSK‐3β: pronounced phosphorylation at select Ser/Thr‐Pro motifs but no phosphorylation at Ser262 in the repeat domain
  FEBS Letters, 1999
• The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 1999
• The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
  Trends in Cell Biology, 1998
• Sequential phosphorylation of Tau by glycogen synthase kinase‐3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer‐specific epitope of antibody AT100 and requires a paired‐helical‐filament‐like conformation
  European Journal of Biochemistry, 1998
• CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
  Annual Review of Cell and Developmental Biology, 1997
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
  FEBS Letters, 1997
• Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5
  European Journal of Biochemistry, 1997
• The Synthesis, Antileukemic Activity, and Crystal Structures of Indirubin Derivatives
  Bulletin of the Chemical Society of Japan, 1996
• Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
  European Journal of Biochemistry, 1994